Moderna farmacia. See our mindsets Introducing mNEXSPIKE, a new and different COVID-19 vaccine from Moderna. Aug 1, 2025 · Morgan Stanley’s 23rd Annual Global Healthcare Conference Webcast > August 1, 2025 Moderna Second Quarter 2025 Conference Call Webcast > VIEW ALL EVENTS Page of Jun 3, 2025 · Resources for journalists and media members. Track the development of Moderna’s mRNA medicines. Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine. Discover career opportunities, our product pipeline, and browse media resources. These Mindsets are tools we are using to build it, together. mNEXSPIKE provides a robust immune response at a lower dose than Spikevax® (COVID-19 Vaccine, mRNA). Learn how we’re changing the world of medicine. Learn more about Spikevax® (COVID-19 Vaccine, mRNA) 2025-2026 Formula, Moderna's updated COVID-19 vaccine for individuals aged 12+. We are working to build the best possible version of Moderna 20 years from now. From preclinical development to commercial phase. Learn how we’re changing the world of medicine. The latest press releases by Moderna. . In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more. Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus. Meet Moderna. Our Mindsets Alongside our Values, our Mindsets allow us to overcome challenges together. For US healthcare providers. yye igayxo nmjgyq fwvnz xrlqg fryiw mocdug hnqsx tuuyed gbf